Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.9600
-0.0250 (-2.54%)
At close: Nov 13, 2026, 4:00 PM EST
1.010
+0.050 (5.21%)
After-hours: Nov 13, 2026, 7:29 PM EST
Acurx Pharmaceuticals Employees
Acurx Pharmaceuticals had 4 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Acurx Pharmaceuticals the 42,074th largest employer in the world and 6,628th in the United States.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,024,251
Market Cap
5.06M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2024 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2023 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Sep 30, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Dec 31, 2021 | 3 | 0 | - | 3 | 0 |
| Mar 31, 2021 | 3 | - | - | 2 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Cardio Diagnostics Holdings | 17 |
| Lantern Pharma | 16 |
| CNS Pharmaceuticals | 8 |
| Aprea Therapeutics | 8 |
| Cadrenal Therapeutics | 5 |
| XTL Biopharmaceuticals | 5 |
| Can-Fite BioPharma | 5 |
ACXP News
- 1 day ago - Acurx price target lowered to $11 from $31 at H.C. Wainwright - TheFly
- 1 day ago - Acurx Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 1 day ago - Acurx Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 1 day ago - Acurx Pharmaceuticals Earnings release: Q3 2026 - Filings
- 1 day ago - Acurx Pharmaceuticals, Inc. Reports Third Quarter 2026 results and provides business update - PRNewsWire
- 18 days ago - Acurx Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 12, 2026 Conference Call and Provide Business Update - PRNewsWire
- 23 days ago - Acurx Announces Publication in ASM Confirming Data on its DNA pol IIIC Inhibitor Pipeline of Antibiotics Demonstrating a Potential Microbiome-Sparing Class Effect - PRNewsWire
- 4 weeks ago - Acurx Pharmaceuticals Transcript: AGM 2026 - Transcripts